5 Best Weight Loss Drug Stocks to Buy Now

Page 1 of 5

In this piece, we will take a look at the five best weight loss drug stocks to buy now. If you want to take a deeper look at the latest trends in the weight loss industry, then read 10 Best Weight Loss Drug Stocks to Buy Now.

5. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Q4 2023 Hedge Fund Shareholders: 60

Bristol-Myers Squibb Company (NYSE:BMY) makes its way on our list of the best weight loss drug stocks due to its acquisition of the pharma firm Amyln in 2012 for a multi billion dollar price tag. This deal saw Bristol-Myers Squibb Company (NYSE:BMY)  partner up with AstraZeneca for Amlyn’s GLP-1 agonist product portfolio. Additionally, it has also licensed its myostatin inhibitor drug as a potential GLP agonist alternative.

As of Q4 2023 end, 60 out of the 933 hedge funds profiled by Insider Monkey had bought Bristol-Myers Squibb Company (NYSE:BMY) ‘s shares. Josh Overdeck and David Siegel’s Two Sigma Advisors was the biggest investor due to its $456 million stake.

Follow Bristol Myers Squibb Co (NYSE:BMY)


Page 1 of 5